Although early diagnosis and treatment dramatically reduce mortality [3], conventional diagnostic methods, such as prostate-specific antigen (PSA) measurements, digital rectal examination, and assessment of lower urinary tract symptoms, lack specificity due to overlap with benign disorders, including prostatitis and benign prostatic hyperplasia (BPH) [4]. This evidence concerns the gene KLK3 and male reproductive organ cancer.